Wednesday, December 26, 2012

Generic Lipitor Recalled Over Glass | Synopsis

Generic Lipitor Recalled Over Glass

Fish Hazards and Controls: More than a Fish Story
Fish Hazards and Controls: More than a Fish Story by The U.S. Food and Drug Administration
License (according to Flickr): United States Government Work
Excerpt:

Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string of manufacturing deficiencies that once led U.S. regulators to bar imports of the Indian company's medicines. Ranbaxy, a subsidiary of Ranbaxy Laboratories Ltd. , India's biggest drugmaker, is operating under increased scrutiny from the U.S. Food and Drug Administration because of quality lapses at multiple Ranbaxy factories over the past several years. The FDA also has alleged the company lied about test results for more than two dozen of its generic drugs several years ago. On Friday, Ranbaxy posted a notice on its U.S. website, saying it's recalling 10-, 20- and 40-milligram doses of tablets of atorvastatin calcium. That's generic Lipitor, the cholesterol fighter that reigned for years as the world's top-selling drug.

People:

Ranbaxy

Overall Sentiment: -0.0673277

Relevance: 0.832129

Additional Info:

Organization: U.S. Food and Drug Administration

Overall Sentiment: -0.0911422

Relevance: 0.707398

Organization: FDA

Overall Sentiment: -0.102037

Relevance: 0.301908

Company: Ranbaxy Pharmaceuticals Inc.

Overall Sentiment: -0.059649

Relevance: 0.41064

Company: Ranbaxy Laboratories Ltd.

Overall Sentiment: 0.115238

Relevance: 0.394611

Country: U.S.

Overall Sentiment: -0.135478

Relevance: 0.49721

Disambiguation: Location | Region | AdministrativeDivision | GovernmentalJurisdiction | FilmEditorReferences:
URL Tags Info

No comments:

Post a Comment